UBX logo

Unity Biotechnology (UBX)

Profile

Full Name

Unity Biotechnology, Inc.

Ticker Symbol

UBX

Exchange

NASDAQ

Country

United States

IPO

May 3, 2018

Indexes

Not included

Employees

16

Key Details

Price

$0.95(-1.86%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.54(+42.96% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 25, 25 HC Wainwright & Co.
Buy
Mar 25, 25 Chardan Capital
Buy
Mar 24, 25 HC Wainwright & Co.
Buy
Mar 10, 25 HC Wainwright & Co.
Buy
Mar 10, 25 Chardan Capital
Buy
Jan 10, 25 Chardan Capital
Buy
Aug 8, 24 HC Wainwright & Co.
Buy
May 15, 24 HC Wainwright & Co.
Buy
Apr 16, 24 HC Wainwright & Co.
Buy
Nov 16, 23 Wedbush
Outperform

Institutional Ownership

  • What is the ticker symbol for Unity Biotechnology?
  • Does Unity Biotechnology pay dividends?
  • What sector is Unity Biotechnology in?
  • What industry is Unity Biotechnology in?
  • What country is Unity Biotechnology based in?
  • When did Unity Biotechnology go public?
  • Is Unity Biotechnology in the S&P 500?
  • Is Unity Biotechnology in the NASDAQ 100?
  • Is Unity Biotechnology in the Dow Jones?
  • When was Unity Biotechnology's last earnings report?
  • When does Unity Biotechnology report earnings?
  • Should I buy Unity Biotechnology stock now?

What is the ticker symbol for Unity Biotechnology?

The ticker symbol for Unity Biotechnology is NASDAQ:UBX

Does Unity Biotechnology pay dividends?

No, Unity Biotechnology does not pay dividends

What sector is Unity Biotechnology in?

Unity Biotechnology is in the Healthcare sector

What industry is Unity Biotechnology in?

Unity Biotechnology is in the Biotechnology industry

What country is Unity Biotechnology based in?

Unity Biotechnology is headquartered in United States

When did Unity Biotechnology go public?

Unity Biotechnology's initial public offering (IPO) was on May 3, 2018

Is Unity Biotechnology in the S&P 500?

No, Unity Biotechnology is not included in the S&P 500 index

Is Unity Biotechnology in the NASDAQ 100?

No, Unity Biotechnology is not included in the NASDAQ 100 index

Is Unity Biotechnology in the Dow Jones?

No, Unity Biotechnology is not included in the Dow Jones index

When was Unity Biotechnology's last earnings report?

Unity Biotechnology's most recent earnings report was on Mar 7, 2025

When does Unity Biotechnology report earnings?

The next expected earnings date for Unity Biotechnology is May 14, 2025

Should I buy Unity Biotechnology stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page